What does a modified-Fibonacci dose-escalation actually correspond to?
<p>Abstract</p> <p>Background</p> <p>In most phase I oncology trials, it is often stated that the dose increments follow a “modified-Fibonacci sequence”. This term, however, is vague.</p> <p>Methods</p> <p>To better characterize this sequence, we reviewed 81 phase I trials based on this concept.</p>...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2012-07-01
|
| Серии: | BMC Medical Research Methodology |
| Предметы: | |
| Online-ссылка: | http://www.biomedcentral.com/1471-2288/12/103 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|